Founded
31 Dec 2002
Website
VCID: 283507
Profile
Corporate information
Official name
VaxInnate Incorporated
Registration country
Official name
VaxInnate Incorporated
Registration country
Investment activity status
Active investor
Company type
A biotechnology company, engages in the development and production of vaccines for pandemic and seasonal influenza diseases.Funding
Funding rounds
(1 Jun 2009)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | United States |
(25 Oct 2006)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | United States |
(25 Oct 2006)
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | United States |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Canaan Partners Venture capital firm with a focus on early stage technology and healthcare companies |
+1 (203) 855-0400 |
Series C |
|
|
CHL Medical Partners Venture capital firm focused on early-stage healthcare sectors. |
+1 (203) 324-7700 |
Series C Series D |
|
|
Healthcare Ventures LLC Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. |
+1 (617) 252-4343 |
N/A |
|
MedImmune Ventures Inc |
+1 (301) 398-4259 |
Series C |
|
New Leaf Venture Partners |
+1 (646) 871-6400 |
Series C |
|
Oxford Bioscience Partners |
+1 (617) 357-7474 |
Series C |
|
Oxford Bioscience Partners IV LP |
N/A | |
|
Wellcome Trust |
Series D |